You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinoma

Citation Tools

Article menu

Download PDFPDF

Clinical/translational cancer immunotherapy
Original research
ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinoma

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Sheng H, Huang Y, Xiao Y, et al
ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinoma
Journal for ImmunoTherapy of Cancer 2020;8:e000340. doi: 10.1136/jitc-2019-000340